Gerald M Reaven Selected Research

Insulin Resistance

07/2007	Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
05/2007	A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.
12/2006	The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.
01/2006	Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes.
07/2005	Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose.
11/2004	Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
07/2004	Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension.
03/2004	Discrimination between obesity and insulin resistance in the relationship with adiponectin.
06/2003	Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology.
03/2002	Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
02/2002	Relative impact of low-density lipoprotein-cholesterol concentration and insulin resistance on carotid wall thickening in nondiabetic, normotensive volunteers.

11	Insulin Resistance 07/2007 - 02/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2008 - 02/2004
3	Weight Loss (Weight Reduction) 05/2006 - 03/2004
2	Hyperinsulinism (Hyperinsulinemia) 05/2008 - 03/2005
2	Syndrome 07/2005 - 10/2004
1	Anoxia (Hypoxia) 12/2007
1	Weight Gain 08/2007
1	Coronary Disease (Coronary Heart Disease) 07/2006
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2006
1	Hypertension (High Blood Pressure) 07/2004
1	Obesity 03/2004
1	Type 2 Diabetes Mellitus (MODY) 02/2004
1	Hypercholesterolemia 04/2003
1	Dyslipidemias (Dyslipidemia) 10/2002
1	Diabetes Mellitus 08/2002
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2002

9	Insulin (Novolin)FDA Link 08/2008 - 04/2003
5	AdiponectinIBA 05/2008 - 03/2004
4	Lipoproteins (Lipoprotein)IBA 07/2007 - 06/2003
4	Glucose (Dextrose)FDA LinkGeneric 07/2006 - 04/2003
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 05/2006 - 08/2002
2	rosiglitazone (Avandia)FDA Link 01/2006 - 01/2006
2	Metformin (Glucophage)FDA LinkGeneric 02/2004 - 06/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2002 - 03/2002
1	pioglitazone (Actos)FDA Link 08/2008
1	LeptinIBA 05/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2008
1	aripiprazole (Abilify)FDA Link 08/2007
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2004
1	One-Step dentin bonding system (One-Step)IBA 10/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004
1	LipidsIBA 04/2003
1	orlistat (Xenical)FDA Link 04/2003
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 10/2002
1	OxidoreductasesIBA 10/2002
1	dimethylargininaseIBA 08/2002
1	LDL CholesterolIBA 02/2002

1	Stents 05/2008
1	Transplants (Transplant) 06/2002